VIVANZA

VIVANZA BIOSCIENCES

Small Cap BSE: 530057 NSE: VIVANZA
₹195.00
6 (3.17%)
As on 09 August, 2022 | 05:00

Vivanza Biosciences Share Price

Vivanza Biosciences Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Vivanza Biosciences Share Returns

  • Over 1 Month 3.17%
  • Over 3 Month 3.37%
  • Over 6 Month 3.42%
  • Over 1 Year 85.27%

Vivanza Biosciences Key Statistics

Vivanza Biosciences Investment Rating

  • Master Rating:
  • Vivanza Biosciences has an operating revenue of Rs. 12.52 Cr. on a trailing 12-month basis. An annual revenue growth of 8% is good, Pre-tax margin of 3% needs improvement, ROE of 9% is fair but needs improvement. The company has a debt to equity of 74%, which is bit higher. It is currently FORMING a base in its weekly chart and is trading around 7% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 10 which is a POOR score indicating inconsistency in earnings, a RS Rating of 69 which is FAIR indicating the recent price performance, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 96 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Institutional holding has remained stable in the last reported quarter. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Vivanza Biosciences Financials
  • Indicator
  • Jun 2022
  • Mar 2022
  • Dec 2021
  • Sep 2021
  • Jun 2021
  • Mar 2021
  • Oper Rev Qtr Cr
  • 2
  • 6
  • 2
  • 2
  • 0
  • 3
  • Operating Expenses Qtr Cr
  • 2
  • 6
  • 1
  • 2
  • 0
  • 3
  • Operating Profit Qtr Cr
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • Depreciation Qtr Cr
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • Interest Qtr Cr
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • Tax Qtr Cr
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • Net Profit Qtr Cr
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0

Vivanza Biosciences Technicals

EMA & SMA

Current Price
195.
6 (3.17%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 180.41
  • 50 Day
  • 169.69
  • 100 Day
  • 155.49
  • 200 Day
  • 133.22
  • 20 Day
  • 174.89
  • 50 Day
  • 173.32
  • 100 Day
  • 147.73
  • 200 Day
  • 133.01

Vivanza Biosciences Resistance and Support

PIVOT
₹189.
Resistance
  • First Resistance
  • 189
  • Second Resistance
  • 189
  • Third Resistance
  • 189
Support
  • First Resistance
  • 189
  • Second Resistance
  • 189
  • Third Resistance
  • 189
  • RSI
  • 60.29
  • MFI
  • 98.08
  • MACD Single Line
  • 3.01
  • MACD
  • 5.08

Vivanza Biosciences Delivery and Volume

  • Period
  • NSE + BSE
    Volume Avg
  • NSE + BSE
    Delivery Volume Avg
  • NSE + BSE
    Delivery Volume %
  • Day
  • Week
  • 1 Month
  • 6 Month
  • 30
  • 2,967
  • 100

Vivanza Biosciences Result Highlights

Vivanza Biosciences Synopsis

BSE-Medical-Diversified

Vivanza Biosciences is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company’s Total Operating Revenue is Rs. 9.15 Cr. and Equity Capital is Rs. 4.00 Cr. for the Year ended 31/03/2022. Vivanza Biosciences Ltd. is a Public Limited Listed company incorporated on 06/03/1982 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24110GJ1982PLC005057 and registration number is 005057.
  • Market Cap
  • 78
  • Sales
  • 11
  • Shares in Float
  • 0.21
  • No of funds
  • 2
  • Yield
  • Book Value
  • 20.38
  • U/D Vol ratio
  • LTDebt / Equity
  • Alpha
  • 0.64
  • Beta
  • -0.2

Vivanza Biosciences

  • Owner Name
  • Jun-22
  • Mar-22
  • Dec-21
  • Sep-21
  • Promoters
  • 47.8%
  • 47.8%
  • 47.8%
  • Financial Institutions/ Banks
  • Individual Investors
  • 5.67%
  • 5.67%
  • 6.53%
  • Others
  • 46.53%
  • 46.53%
  • 45.67%

Vivanza Biosciences Management

  • Name
  • Designation
  • Mr. Parikh H A
  • Director
  • Ms. Patel M S
  • Director
  • Mr. Bhatt G B
  • Director
  • Mr. Shah S D
  • Director

Vivanza Biosciences Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Vivanza Biosciences Corporate Action

  • Date
  • Purpose
  • Remarks
  • 2022-07-21
  • Quarterly Results
  • 2022-06-21
  • Preferential issue of shares
  • 2022-06-15
  • A.G.M.
  • 2022-05-27
  • Audited, Quarterly Results & Pref issue
  • 2022-02-10
  • Quarterly Results

Vivanza Biosciences FAQs

What is Share Price of Vivanza Biosciences ?

Vivanza Biosciences share price is ₹195 As on 09 August, 2022 | 04:46

What is the Market Cap of Vivanza Biosciences ?

The Market Cap of Vivanza Biosciences is ₹78 Cr As on 09 August, 2022 | 04:46

What is the P/E ratio of Vivanza Biosciences ?

The P/E ratio of Vivanza Biosciences is 913.3 As on 09 August, 2022 | 04:46

What is the PB ratio of Vivanza Biosciences ?

The PB ratio of Vivanza Biosciences is 22.3 As on 09 August, 2022 | 04:46

Q1FY23